Jan. 16 (Bloomberg) — Citigroup Inc., the third-biggest U.S. bank, reported fourth-quarter profit that missed Wall Street estimates as bond trading slumped. The stock fell more than 3% in New York trading.
Net income more than doubled to $2.69 billion from $1.2 billion a year earlier, when Citigroup reported a $653 million charge, and earnings per share rose to 85 cents from 38 cents, the New York-based bank said today in a statement. Excluding accounting charges and special items, profit was 82 cents a share, less than the 95-cent average estimate of 26 analysts surveyed by Bloomberg.
CEO Michael Corbat, 53, sought to cut costs and boost revenue even as trading from bond and foreign exchange markets came under pressure. The effort was marred by a 15% drop in fixed income revenue excluding accounting charges. Adjusted profit decreased 8% at the securities and banking unit and 16% for global consumer banking, according to the firm.
“We haven’t seen any rebound in fixed income,” Marty Mosby, a bank analyst with Guggenheim Securities LLC, said in an interview before the results were announced. That’s what the bank “really needs because they are more heavily dependent on that than the other money-center banks,” he said. Mosby has a buy rating on the stock with a $68 price target.
Top Gas Utility Stocks To Buy For 2015: Giga-tronics Inc (GIGA)
Giga-tronics Incorporated (Giga-tronics), incorporated on March 5, 1980, includes the operations of the Giga-tronics Division and Microsource Inc. (Microsource), a wholly owned subsidiary. Giga-tronics Division designs, manufactures and markets a line of test and measurement equipment used in the development, test and maintenance of wireless communications products and systems, flight navigational equipment, electronic defense systems and automatic testing systems. These products are used primarily in the design, production, repair and maintenance of commercial telecommunications, radar, and electronic warfare equipment. The Company manufactures products used in test, measurement and control. The Company has two segments: Giga-tronics Division and Microsource. In April 2013, it completed the sale of its product line known as SCPM to Teradyne, Inc.
Giga-tronics
The Giga-tronics Division produces signal sources, generators and sweepers, and power measurement instruments for use in the microwave and radio frequency (RF) range (10 kilohertz (kHz) to 50 gigahertz (GHz)). Within each product line are a number of different models and options allowing customers to select frequency range and specialized capabilities, features and functions. The end-user markets for these products can be divided into three segments: commercial telecommunications, radar and electronic warfare. These instruments are used in the design, production, repair and maintenance and calibration of other manufacturers' products, from discrete components to complex systems.
The Giga-tronics Division also produces switch modules and interface adapters that operates with a bandwidth from direct current (DC) to optical frequencies. These switch modules may be incorporated within its customers' automated test equipment. The end-user markets for these products are primarily related to defense, aeronautics, communications, satellite and electronic warfare, commercial aviation and semiconductors.
The Microsource segment develops and manufactures a broad line of yttrium, iron, garnet (YIG) tuned oscillators, filters and microwave synthesizers, which are used by its customers in operational applications and in manufacturing a variety of microwave instruments or devices.
Giga-tronics competes with Agilent, Anritsu, EADS, Aeroflex and Rohde & Schwarz.
Advisors' Opinion:- [By Monica Gerson]
Giga-tronics (NASDAQ: GIGA) dropped 14.84% to $1.32. Giga-tronics' trailing-twelve-month profit margin is -30.58%.
MER Telemanagement Solutions (NASDAQ: MTSL) dropped 14.62% to $2.09 after the company terminated MVNE solution provider agreement with SBC Communications.
Best Healthcare Technology Stocks To Watch Right Now: Stepan Co (SCL)
Stepan Company, incorporated on February 19, 1959, produces specialty and intermediate chemicals, which are sold to other manufacturers and then made into a variety of end products. The Company serves principal markets, such as manufacturers of cleaning and washing compounds (including detergents, shampoos, fabric softeners, toothpastes and household cleaners), paints, cosmetics, food and beverages, agricultural products, plastics, furniture, automotive equipment, insulation and refrigeration. The Company has three segments: surfactants, polymers and specialty products. The Company operates in the geographical regions of North America, Europe, Latin America and Asia. As of December 31, 2012, the Surfactants segment accounted to 72%, Polymers segment accounted to 24% and Specialty segment accounted to 4% of the Company�� revenues. On March 22, 2012, the Company increased its controlling interest in Stepan Philippines Inc from 89% to 100%.
Surfactants
Surfactants are used in a variety of consumer and industrial cleaning compounds as well as in agricultural products, lubricating ingredients, biodiesel and other specialized applications. The Surfactants are principal ingredients in consumer and industrial cleaning products, such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Surfactants are manufactured at six North American sites (five in the United States and one in Canada), three European sites (United Kingdom, France and Germany), and three Latin American sites (Mexico, Brazil and Colombia), and one Asian site (Philippines and Singapore). The Company also holds a 50% ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields.
Polymers
Polymers generate its revenues primarily from the sale of polyols and phthalic anhydride used in plastics, buildi! ng materials and refrigeration systems. It includes two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board for thermal insulation in the construction industry. Polyols are also a base raw material for flexible foams, coatings, adhesives, sealants and elastomers.
Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, phthalic anhydride is used internally in the production of polyols. In the United States, polymer product lines are manufactured at the Company�� Millsdale, Illinois, site. In Europe, polyols are manufactured at the Company�� subsidiaries in Germany and Poland. In Asia, polyols are produced at the Company�� 80% owned joint venture in Nanjing, China.
Specialty Products
Specialty products are used in food, flavoring and pharmaceutical applications. It includes flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are primarily manufactured at the Company�� Maywood, New Jersey, site.
Advisors' Opinion:- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Stepan (NYSE: SCL ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Stepan doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue decreased 4.8%, and inventory increased 30.6%. Comparing the latest quarter to the prior-year quarter, the story looks potentially problematic. Revenue dropped 1.9%, and inventory grew 30.6%. Over the sequential quarterly period, the trend looks OK but not great. Revenue grew 6.9%, and inventory grew 9.5%. - [By Monica Gerson]
Stepan Company (NYSE: SCL) is expected to report its Q3 earnings at $0.93 per share on revenue of $467.40 million.
Lennox International (NYSE: LII) is projected to report its Q3 earnings at $1.28 per share on revenue of $877.87 million.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Stepan (NYSE: SCL ) , whose recent revenue and earnings are plotted below.
Best Healthcare Technology Stocks To Watch Right Now: NeuroMetrix Inc.(NURO)
NeuroMetrix, Inc., a science-based health care company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease, and spinal stenosis. The company focuses on diagnosis and treatment of the neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include the ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the diagnosis and evaluation of CTS, low back and leg pain, and DPN; and the NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care, as well as consumables and accessories for use with its neurodiagnostic equipment. The company is also developing SENSUS pain therapy device, a transcutaneous electrical nerve stimul ator used in the management of chronic pain, such as that caused by DPN; and ADVANCE CTS, a version of the ADVANCE NCS/EMG device for the detection of CTS in people with diabetes. The company distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, and hospitals consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology/podiatry market in the United States and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Bryan Murphy]
My recent love affair with Neurometrix Inc. (NASDAQ:NURO) hasn't exactly been a veiled secret. I first pointed out this diabetes-diagnostics stock was working on a technical breakout effort in early October, and I penned two more bullish-progress reports on NURO in November. Yet, the Neurometrix rally is still in its infancy, when you take a step back and look at the bigger weekly chart.
- [By Bryan Murphy]
If you missed the recent surges from Neurometrix Inc. (NASDAQ:NURO) and/or OXiGENE Inc. (NASDAQ:OXGN), and decided to skip an entry on either or both because they were too frothy at the time, then here's some good news.... you're getting a second chance. Both NURO and OXGN are getting their proverbial second wind, and they're doing so at a price much lower than the price you would have had to pay for either just a few days ago. There's just one catch - you may want to hurry of you want in. This second wind is unfurling as rapidly as the first surges did.
Best Healthcare Technology Stocks To Watch Right Now: Soditech Ingenierie SA (SEC)
Soditech Ingenierie SA is a France-based company that is primarily engaged in electronic and mechanical engineering services in various sectors. The Company�� activity is organized into three sectors: Defense & Research, Space and Energy & Nuclear. It provides specialized services in four fields: aerospace, covering communication satellites, observation satellites and space stations; automotive, providing such services as engine design and plasturgy for equipment manufacturers; aeronautics, offering structural research for aircraft makers, instruments or electro-mechanical systems for assisting pilots and others, and defense, providing engineering of numerous tests and trials systems, with or without implementations, among others. The Company also offers additional services, such as energy forecasting and environmental analysis, environmental management system, and others. In May 2014, it restructured company into three main divisions: Defense & Research, Space and Energy & Nuclear. Advisors' Opinion:- [By Omar Venerio]
Over the past few days, hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Blackhill Capital Inc., a financial investment advisory firm headquartered in Morristown, New Jersey.
- [By ovenerio]
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Abner Herrman & Brock LLC, which provides portfolio management for high net worth individuals, endowments, and corporate retirement plans.Recently the fund reported its equity portfolio, as at the end of June. The total value of the portfolio amounted to $331.2 million, up from $311.3 million disclosed at the end of the previous quarter. Consequently, the fund's total return was 6.4% in the last quarter. The filing revealed that at the end of June, the fund added 4 new positions to its equity portfolio, and sold out of 3 other companies. The top ten portfolio holdings as of the end of the quarter represented 30.85%. The largest changes from previous 13-F麓s fillings are in the energy sector (3.5%) followed by the reduction of financials and industrials.In this article, we have selected three companies, in which the fund holds the largest stakes, in terms of market value.The first on the list is Merck & Co. (MRK), in which the fund disclosed a $15.2 million stake with over 263,570 shares. The company is a leading global drugmaker, producing a wide range of prescription drugs in many therapeutic classes in the U.S. and abroad. It has improved earnings per share by 9.6% in the most recent quarter compared to the same quarter a year ago. With respect to price performance, this stock has enjoyed a rise of 26.85% which was in line with the performance of the market. It has a proven commitment to returning cash to investors, with a current dividend yield of 3.0% which is considered good to protect investor麓s purchasing power. Other hedge
- [By Vanina Egea]
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Blackhill Capital Inc., a financial investment advisory firm headquartered in Morristown, N.J.
- [By Victor Selva]
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let's concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Tudor Investment Corp in which Paul Tudor Jones (Trades, Portfolio) serve as chief investment officer.
No comments:
Post a Comment